Skip to content

LENSAR, Inc. LNSR Current ratio

Current ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Staar Surgical logo
Staar SurgicalSTAA
5.1×+0.3×
Bausch + Lomb logo
Bausch + LombBLCO
1.5×0.0×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
5.8×+2.3×
IAR
Integra LifeSciencesIART
3.4×+2.2×
ITG
Integer HoldingsITGR
3.8×+0.4×

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on the most recent quarter.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s current ratio?
LENSAR, Inc. (LNSR) reported current ratio of 2.4× in Q1 2026.
How has LENSAR, Inc.'s current ratio changed year-over-year?
LENSAR, Inc.'s current ratio increased by 31.6% year-over-year, from 1.8× to 2.4×.
What is the long-term trend for LENSAR, Inc.'s current ratio?
Over 5 years (2020 to 2025), LENSAR, Inc.'s current ratio has grown at a -30.1% compound annual growth rate (CAGR), from 6.9× to 1.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.